Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
EDITORIAL
Athena Poppas
No abstract text is available yet for this article.
January 15, 2021: Journal of the American College of Cardiology
#2
LETTER
Jianhua Wu, Mamas A Mamas, Mark A de Belder, John E Deanfield, Chris P Gale
No abstract text is available yet for this article.
January 12, 2021: Journal of the American College of Cardiology
#3
Thomas M Maddox, James L Januzzi, Larry A Allen, Khadijah Breathett, Javed Butler, Leslie L Davis, Gregg C Fonarow, Nasrien E Ibrahim, JoAnn Lindenfeld, Frederick A Masoudi, Shweta R Motiwala, Estefania Oliveros, J Herbert Patterson, Mary Norine Walsh, Alan Wasserman, Clyde W Yancy, Quentin R Youmans
No abstract text is available yet for this article.
January 4, 2021: Journal of the American College of Cardiology
#4
Sunil V Rao, Mladen I Vidovich, Ian C Gilchrist, Rajiv Gulati, J Antonio Gutierrez, Connie N Hess, Prashant Kaul, Sara C Martinez, Jennifer Rymer
No abstract text is available yet for this article.
December 28, 2020: Journal of the American College of Cardiology
#5
EDITORIAL
Athena Poppas, Frederick A Masoudi
No abstract text is available yet for this article.
December 19, 2020: Journal of the American College of Cardiology
#6
Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly
No abstract text is available yet for this article.
December 17, 2020: Journal of the American College of Cardiology
#7
Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly
AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline...
December 10, 2020: Journal of the American College of Cardiology
#8
REVIEW
Gregory A Roth, George A Mensah, Catherine O Johnson, Giovanni Addolorato, Enrico Ammirati, Larry M Baddour, Noël C Barengo, Andrea Z Beaton, Emelia J Benjamin, Catherine P Benziger, Aimé Bonny, Michael Brauer, Marianne Brodmann, Thomas J Cahill, Jonathan Carapetis, Alberico L Catapano, Sumeet S Chugh, Leslie T Cooper, Josef Coresh, Michael Criqui, Nicole DeCleene, Kim A Eagle, Sophia Emmons-Bell, Valery L Feigin, Joaquim Fernández-Solà, Gerry Fowkes, Emmanuela Gakidou, Scott M Grundy, Feng J He, George Howard, Frank Hu, Lesley Inker, Ganesan Karthikeyan, Nicholas Kassebaum, Walter Koroshetz, Carl Lavie, Donald Lloyd-Jones, Hong S Lu, Antonio Mirijello, Awoke Misganaw Temesgen, Ali Mokdad, Andrew E Moran, Paul Muntner, Jagat Narula, Bruce Neal, Mpiko Ntsekhe, Glaucia Moraes de Oliveira, Catherine Otto, Mayowa Owolabi, Michael Pratt, Sanjay Rajagopalan, Marissa Reitsma, Antonio Luiz P Ribeiro, Nancy Rigotti, Anthony Rodgers, Craig Sable, Saate Shakil, Karen Sliwa-Hahnle, Benjamin Stark, Johan Sundström, Patrick Timpel, Imad M Tleyjeh, Marco Valgimigli, Theo Vos, Paul K Whelton, Magdi Yacoub, Liesl Zuhlke, Christopher Murray, Valentin Fuster
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consistent estimates of population health over time, used all available population-level data sources on incidence, prevalence, case fatality, mortality, and health risks to produce estimates for 204 countries and territories from 1990 to 2019...
December 3, 2020: Journal of the American College of Cardiology
#9
Paul A Heidenreich, N A Mark Estes, Gregg C Fonarow, Corrine Y Jurgens, Michelle M Kittleson, Joseph E Marine, David D McManus, Robert L McNamara
No abstract text is available yet for this article.
December 1, 2020: Journal of the American College of Cardiology
#10
EDITORIAL
Gregory A Roth, George A Mensah, Valentin Fuster
No abstract text is available yet for this article.
November 30, 2020: Journal of the American College of Cardiology
#11
Dharam J Kumbhani, Christopher P Cannon, Craig J Beavers, Deepak L Bhatt, Adam Cuker, Ty J Gluckman, Joseph E Marine, Roxana Mehran, Steven R Messe, Nimesh S Patel, Benjamin E Peterson, Kenneth Rosenfield, Sarah A Spinler, Vinod H Thourani
No abstract text is available yet for this article.
November 26, 2020: Journal of the American College of Cardiology
#12
Mark A Creager, Naomi M Hamburg, Keith D Calligaro, Ana I Casanegra, Rosario Freeman, Phyllis A Gordon, Heather L Gornik, Esther S H Kim, Nicholas J Leeper, Geno J Merli, Khusrow Niazi, Jeffrey W Olin, Rene Quiroz, Elona Rrapo Kaso, Suman Wasan, Andrew R Waxler, Christopher J White, Khendi White Solaru, Marlene S Williams
This article has been temporarily removed as it was inadvertently posted ahead of an agreed-upon embargo. The article will be reinstated upon embargo expiry. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
November 26, 2020: Journal of the American College of Cardiology
#13
Biykem Bozkurt, Ray E Hershberger, Javed Butler, Maria Lizza Isler, Kathleen L Grady, James K Kirklin, Paul A Heidenreich, William S Weintraub
This article has been temporarily removed as it was inadvertently posted ahead of an agreed-upon embargo. The article will be reinstated upon embargo expiry. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
November 26, 2020: Journal of the American College of Cardiology
#14
Steve R Ommen, Seema Mital, Michael A Burke, Sharlene M Day, Anita Deswal, Perry Elliott, Lauren L Evanovich, Judy Hung, José A Joglar, Paul Kantor, Carey Kimmelstiel, Michelle Kittleson, Mark S Link, Martin S Maron, Matthew W Martinez, Christina Y Miyake, Hartzell V Schaff, Christopher Semsarian, Paul Sorajja
No abstract text is available yet for this article.
November 20, 2020: Journal of the American College of Cardiology
#15
Steve R Ommen, Seema Mital, Michael A Burke, Sharlene M Day, Anita Deswal, Perry Elliott, Lauren L Evanovich, Judy Hung, José A Joglar, Paul Kantor, Carey Kimmelstiel, Michelle Kittleson, Mark S Link, Martin S Maron, Matthew W Martinez, Christina Y Miyake, Hartzell V Schaff, Christopher Semsarian, Paul Sorajja
AIM: This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases...
November 17, 2020: Journal of the American College of Cardiology
#16
Paaladinesh Thavendiranathan, Tomoko Negishi, Emily Somerset, Kazuaki Negishi, Martin Penicka, Julie Lemieux, Svend Aakhus, Sakiko Miyazaki, Mitra Shirazi, Maurizio Galderisi, Thomas H Marwick
BACKGROUND: In patients at risk of cancer therapy-related cardiac dysfunction (CTRCD), initiation of cardio-protective therapy (CPT) is constrained by the low sensitivity of EF for minor changes in LV function. Global longitudinal strain (GLS) is a robust and sensitive marker of LV dysfunction, but existing observational data have been insufficient to support a routine GLS-guided strategy for CPT. OBJECTIVE: To identify whether GLS-guided CPT prevents reduction in LVEF in patients undergoing potentially cardiotoxic chemotherapy, compared with usual care...
November 16, 2020: Journal of the American College of Cardiology
#17
Kazuma Oyama, Remo H M Furtado, Antonio Fagundes, Thomas A Zelniker, Minao Tang, Julia Kuder, Sabina A Murphy, Andrew Hamer, Huei Wang, Anthony C Keech, Robert P Giugliano, Marc S Sabatine, Brian A Bergmark
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors induce plaque regression and reduce the risk of coronary revascularization overall. OBJECTIVES: To evaluate the ability of PCSK9 inhibitors to reduce the risk of complex coronary atherosclerosis requiring revascularization. METHODS: FOURIER was a randomized trial of the PCSK9 inhibitor evolocumab vs. placebo in 27,564 patients with stable atherosclerosis on statin therapy followed for a median of 2...
November 11, 2020: Journal of the American College of Cardiology
#18
Carlos G Santos-Gallego, Ariana P Vargas-Delgado, Juan Antonio Requena, Alvaro Garcia-Ropero, Donna Mancini, Sean Pinney, Frank Macaluso, Samantha Sartori, Merce Roque, Fernando Sabatel-Perez, Anderly Rodriguez Cordero, M Urooj Zafar, Icilma Fergus, Farah Atallah-Lajam, Johanna P Contreras, Cathleen Varley, Pedro R Moreno, Vivian M Abascal, Anuradha Lala, Ronald Tamler, Javier Sanz, Valentin Fuster, Juan J Badimon
BACKGROUND: Large clinical trials established the benefits of SGLT2 inhibitors in patients with diabetes and with heart failure with reduced ejection fraction (HFrEF). The early and significant improvement in clinical outcomes is likely explained by effects beyond a reduction in hyperglycemia OBJECTIVES: To assess the effect of empagliflozin on LV function and volumes, functional capacity and quality of life (QoL) in non-diabetic HFrEF patients. METHODS: In this double-blind, placebo-controlled trial, non-diabetic HFrEF patients (n=84) were randomized to empagliflozin or placebo for six months...
November 9, 2020: Journal of the American College of Cardiology
#19
Natalie A Cameron, Rebecca Molsberry, Jacob B Pierce, Amanda M Perak, William A Grobman, Norrina B Allen, Philip Greenland, Donald M Lloyd-Jones, Sadiya S Khan
BACKGROUND: Rates of maternal mortality are increasing in the United States with significant rural-urban disparities. Pre-pregnancy hypertension is a well-established risk factor for adverse maternal and offspring outcomes. OBJECTIVES: The purpose of this study was to inform community-engaged prevention and policy strategies, this study sought to describe trends in maternal pre-pregnancy hypertension among women in rural and urban areas in 2007 to 2018. METHODS: We performed a nationwide, serial cross-sectional study using maternal data from all live births in women age 15 to 44 years between 2007 and 2018 (CDC Natality Database)...
November 7, 2020: Journal of the American College of Cardiology
#20
EDITORIAL
Philippe Pibarot, Patrizio Lancellotti, Jagat Narula
No abstract text is available yet for this article.
November 6, 2020: Journal of the American College of Cardiology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
